IR@PKUHSC  > 北京大学临床肿瘤学院
学科主题临床医学
Epidermal growth factor receptor genotype in plasma DNA and outcome of chemotherapy in the Chinese patients with advanced non-small cell lung cancer
Zhuo Ming-lei1; Wu Mei-na1; Zhao Jun1; Song, Sonya Wei2; Bai Hua1; Wang Shu-hang1; Yang Lu1; An Tong-tong1; Wang Xin1; Duan Jian-chun1; Wang Yu-yan1; Guo Qing-zhi1; Liu Xu-yi1; Liu Ning-hong1; Wang Jie1
关键词Non-small Cell Lung Cancer Plasma Epidermal Growth Factor Receptor Mutation First Line Chemotherapy Prognosis Targeted Therapy Gefitinib
刊名CHINESE MEDICAL JOURNAL
2011-11-05
DOI10.3760/cma.j.issn.0366-6999.2011.21.014
124期:21页:3510-3514
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Medicine, General & Internal
研究领域[WOS]General & Internal Medicine
关键词[WOS]PHASE-III TRIAL ; MUTATIONS ; GEFITINIB ; ADENOCARCINOMA ; CARBOPLATIN ; PACLITAXEL
英文摘要

Background The genotype of epidermal growth factor receptor (EGFR) is associated with tyrosine kinase inhibitor and effectiveness of therapy, but its role in cytotoxic chemotherapy is still unknown. Previous studies indicated that certain EGFR mutations were associated with response and progression free survival following platinum based chemotherapy. Our recent studies have identified that EGFR genotypes in the tumour tissues were not associated with response to the first-line chemotherapy in Chinese patients with advanced non-small cell lung cancer (NSCLC). In this study, we investigated associations of EGFR genotypes from plasma of patients with advanced NSCLC and response to first-line chemotherapy and prognosis.

Methods We enrolled 145 advanced NSCLC patients who had received first-line chemotherapy in our department. We examined plasma EGFR genotypes for these patients and associations of EGFR mutations with response to chemotherapy and clinical outcomes.

Results There were 54 patients with known EGFR mutations and 91 cases of wild types. No significant difference was detected in the response rate to first-line chemotherapy between mutation carriers and wild-type patients (37.0% vs. 31.9%). The median survival time and 1-, 2-year survival rates were higher in mutation carriers than wild-types (24 months vs. 18 months, 85.7% vs. 65.7% and 43.7% vs. 25.9%, P=0.047). Clinical stage (IV vs. IIIb), response to the first-line chemotherapy (partial vs. no) and EGFR genotype were independent prognostic factors.

Conclusion Plasma EGFR mutations in the Chinese patients with advanced NSCLC is not a predictor for the response to first-line chemotherapy, but an independent prognostic factor indicating longer survival. Chin Med J2011;124(21):3510-3514

语种英语
WOS记录号WOS:000297658200015
项目编号2006AA02A401 ; 30772472 ; 2-013-39
资助机构National High Technology Research and Development Program of China ("863" Program) ; Capital Development Foundation ; Peking University
引用统计
被引频次:6[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/54639
专题北京大学临床肿瘤学院
北京大学临床肿瘤学院_胸部肿瘤内科
作者单位1.Peking Univ, Sch Oncol, Dept Thorac Med Oncol,Minist Educ, Beijing Canc Hosp & Inst,Key Lab Carcinogenesis &, Beijing 100142, Peoples R China
2.Capital Med Univ, Beijing Shijitan Hosp, Lab Oncol, Beijing 100038, Peoples R China
推荐引用方式
GB/T 7714
Zhuo Ming-lei,Wu Mei-na,Zhao Jun,et al. Epidermal growth factor receptor genotype in plasma DNA and outcome of chemotherapy in the Chinese patients with advanced non-small cell lung cancer[J]. CHINESE MEDICAL JOURNAL,2011,124(21):3510-3514.
APA Zhuo Ming-lei.,Wu Mei-na.,Zhao Jun.,Song, Sonya Wei.,Bai Hua.,...&Wang Jie.(2011).Epidermal growth factor receptor genotype in plasma DNA and outcome of chemotherapy in the Chinese patients with advanced non-small cell lung cancer.CHINESE MEDICAL JOURNAL,124(21),3510-3514.
MLA Zhuo Ming-lei,et al."Epidermal growth factor receptor genotype in plasma DNA and outcome of chemotherapy in the Chinese patients with advanced non-small cell lung cancer".CHINESE MEDICAL JOURNAL 124.21(2011):3510-3514.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhuo Ming-lei]的文章
[Wu Mei-na]的文章
[Zhao Jun]的文章
百度学术
百度学术中相似的文章
[Zhuo Ming-lei]的文章
[Wu Mei-na]的文章
[Zhao Jun]的文章
必应学术
必应学术中相似的文章
[Zhuo Ming-lei]的文章
[Wu Mei-na]的文章
[Zhao Jun]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。